Expression data from Sus scrofa atria

  • Mien Cheng Chen (Contributor)
  • Jen Ping Chang (Contributor)
  • Tzu-Hao Chang (Contributor)
  • Sheng Da Hsu (Contributor)
  • Hsien Da Huang (Contributor)
  • Wan Chun Ho (Contributor)
  • Feng Sheng Wang (Contributor)
  • Chang Chun Hsiao (Contributor)
  • Wen Hao Liu (Contributor)



Accession Number: GSE43072

GPL3533: [Porcine] Affymetrix Porcine Genome Array

Organism: Sus scrofa

Published on 2015-02-01

Regulatory Mechanisms of Atrial Remodeling of Mitral Regurgitation Pigs

Overall Design:
This study enrolled 6 pigs (age: 18 months) and divided into three groups: mitral regurgitation pigs (MR) (n = 2; 2 males sacrificed 12 months after surgery), MR pigs treated with valsartan (MRV) (n = 2; 2 males age-matched to MR sacrificed 12 months after surgery), and normal control pigs (NC) (n = 2; 2 males age-matched to MR pigs). Valsartan (3.43 mg/kg/day), a type I angiotensin II receptor blocker, was administered from one week before surgery and then daily after surgery in the MRV group. We sought to systemically elucidate critical differences in the alteration of RNA expression pattern between the atrial myocardium of pigs with and without MR, and between the atrial myocardium of MR pigs with and without valsartan using high-density oligonucleotide microarrays and functional network enrichment analysis.

Name: Tzu-Hao Chang
Organization: Taipei Medical University
Deparment: Graduate Institute of Biomedical Informatics
Address: 250 Wu-Xin Street Taipei Taiwan

Organization: Affymetrix, Inc.
Address: Santa Clara CA 95051 USA
Email: [email protected], [email protected]
Phone: 888-362-2447
發行者Gene Expression Omnibus